Perioperative immune checkpoint inhibition for colorectal cancer: recent advances and future directions

por Chen, Jiao-Ting, Zhou, Yu-Wen, Han, Ting-Rui, Wei, Jun-Lun, Qiu, Meng
Publicado 2023

Biweekly Raltitrexed Combined With Irinotecan as Second-Line Therapy for Patients With Metastatic Colorectal Cancer: A Phase II Trial

por Cheng, Ke, Zhou, Yu-Wen, Chen, Ye, Li, Zhi-Ping, Qiu, Meng, Liu, Ji-Yan
Publicado 2022

Increased proportion of the squamous cell carcinoma component is associated with worse survival in resected gastric adenosquamous carcinoma: A STROBE compliant cohort study

por Li, Hong-Shuai, Chen, Ye, Zhang, Ming-Yi, Cheng, Ke, Zhou, Yu-Wen, Liu, Ji-Yan
Publicado 2020

Inflammation‐nutritional markers of peripheral blood could predict survival in advanced non‐small‐cell lung cancer patients treated with PD‐1 inhibitors

por Pu, Dan, Xu, Qian, Zhou, Lai‐Yan, Zhou, Yu‐Wen, Liu, Ji‐Yan, Ma, Xue‐Lei
Publicado 2021

Predictive Risk Factors and Online Nomograms for Synchronous Colon Cancer With Liver Metastasis

por Zhu, Ya-Juan, Chen, Ye, Hu, Hao-Yue, Zhou, Yu-Wen, Zhu, Yue-Ting, Liu, Ji-Yan
Publicado 2020

Pathological response and safety of FOLFOXIRI for neoadjuvant treatment of high-risk relapsed locally advanced colon cancer: study protocol for a single-arm, open-label phase II tr...

por Chen, Xiaorong, Leng, Weibing, Zhou, YuWen, Yu, Yongyang, Meng, Wenjian, Cao, Peng, Wang, Ziqiang, Qiu, Meng
Publicado 2023

Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into ura...

por Zhou, Yu‐Wen, Long, Yi‐Xiu, Song, Kun, Liang, Li‐Bo, Cheng, Ke, Chen, Ye, Liu, Ji‐Yan
Publicado 2021

Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies

por Zhou, Yu-Wen, Xie, Yao, Tang, Lian-Sha, Pu, Dan, Zhu, Ya-Juan, Liu, Ji-Yan, Ma, Xue-Lei
Publicado 2021

Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management

por Zhou, Yu-Wen, Zhu, Ya-Juan, Wang, Man-Ni, Xie, Yao, Chen, Chao-Yue, Zhang, Tao, Xia, Fan, Ding, Zhen-Yu, Liu, Ji-Yan
Publicado 2019

First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component...

por Zhou, Yu‐Wen, Long, Yi‐Xiu, Chen, Ye, Liu, Ji‐Yan, Pu, Dan, Huang, Jia‐Yan, Bi, Feng, Li, Qiu, Gou, Hong‐Feng, Qiu, Meng
Publicado 2021

Efficacy and safety of raltitrexed plus S-1 versus regorafenib in patients with refractory metastatic colorectal cancer: a real-world propensity score matching study

por Zhou, Yu-Wen, Wang, Jia-Ling, Li, Qing-Fang, He, Yuan-Lin, Li, Lin-Juan, Liu, Rui-Zhi, Chen, Ye, Zhang, Shuang, Qiu, Meng, Liu, Ji-Yan
Publicado 2022

Immune-Related Pneumonitis Was Decreased by Addition of Chemotherapy with PD-1/L1 Inhibitors: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (RCTs)

por Long, Yi-Xiu, Sun, Yue, Liu, Rui-Zhi, Zhang, Ming-Yi, Zhao, Jing, Wang, Yu-Qing, Zhou, Yu-Wen, Cheng, Ke, Chen, Ye, Zhu, Cai-Rong, Liu, Ji-Yan
Publicado 2022

Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer

por Zhu, Yue-Ting, Chen, Xin-Zu, Chen, Ye, Zhou, Yu-Wen, Tang, Lian-Sha, Luo, De-Yun, Li, Qiu, Qiu, Meng, Wang, Xin, Cao, Dan, Yang, Yu, Shen, Ya-Li, Li, Zhi-Ping, Bi, Feng, Liu, Ji-Yan, Gou, Hong-Feng
Publicado 2020